Last reviewed · How we verify
Glucosamine and chondroitin sulfate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Glucosamine and chondroitin sulfate (Glucosamine and chondroitin sulfate) — Ardabil University of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glucosamine and chondroitin sulfate TARGET | Glucosamine and chondroitin sulfate | Ardabil University of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glucosamine and chondroitin sulfate CI watch — RSS
- Glucosamine and chondroitin sulfate CI watch — Atom
- Glucosamine and chondroitin sulfate CI watch — JSON
- Glucosamine and chondroitin sulfate alone — RSS
Cite this brief
Drug Landscape (2026). Glucosamine and chondroitin sulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/glucosamine-and-chondroitin-sulfate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab